# Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy

> **NCT07511543** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Population Health Research Institute** · enrollment: 100 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Semaglutide

## Key facts

- **NCT ID:** NCT07511543
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07511543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07511543, "Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07511543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*